About this trial
The purpose of this study is to prospectively evaluate the process of implementing HFNO in several MSF projects, varying according to geographical and programmatic contexts, population, health structures, human resources, and management. It will generate evidence on the operational feasibility (in terms of human resources, equipment, logistics and costs) of integrating HFNO into PICU standard of care, as well as on the users' and caregivers' perspectives on HFNO and on the children clinical outcomes observed where HFNO is implemented. This relevant information will guide MSF in the decision making of scaling up HFNO therapy in its projects.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
prescription of HFNO by clinician
parent consenting to the use of the data
Disqualifiers
None
Trial population
MSF pediatric ICU in 4 sites (Herat- Afghanistan, Kenema- Sierra Leone, Goyalmara hospital for Rohingya refugee - Bangladesh, Khamir- Yemen)
Trial design
Other
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Recovery with SPO2 above 92%
Other outcomes
Acceptability, feasibility and perception from the caretaker point of view
interview of the caretaker
Acceptability, feasibility and perception from the health staff point of view
Interview of the health staffs (doctors, nurses, biomed, managers, logisticians)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Epicentre
Lead sponsor
MOH Afghanistan
Collaborator
MOH Bangladesh
Collaborator
MOH Sierra Leone
Collaborator
MOH Yemen
Collaborator
MSF Médecins Sans Frontières Belgium
Collaborator
MSF Médecins Sans Frontières France
Collaborator
Fisher and Paykel Healthcare
Collaborator
This trial is not recruiting at the moment. You can still explore other options: